Covid Jabs for Kids Likely by First Quarter of 2022: Adar Poonawalla
3 years, 5 months ago

Covid Jabs for Kids Likely by First Quarter of 2022: Adar Poonawalla

News 18  

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another Covid-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. “By the first quarter of 2022, we will have a vaccine for kids”, he told the media following the meeting. At the time of launch, everybody will.” SII has also applied for Emergency Use Authorization for Novavax to the Central Drug Standard Control Organisation today. An expert panel of the Central Drug Authority had last month recommended granting permission to SII for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions.

India Vaccine First Quarter Sii Covovax 2022 Adar  poonawalla  2022  adar  launched  likely  quarter  drug  jabs  covovax  trials  support  india  children  covid  vaccine  kids

History of this topic

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?
4 months, 2 weeks ago

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?

LA Times  

New COVID-19 vaccines are expected to be available as soon as this week, a promising development amid California’s potent and enduring summer wave of the disease. “I have a tremendous empathy, having seen people struggle with long COVID in their 30s and 40s, people who you might think were otherwise low-risk,” Dr. Peter Marks, the FDA’s vaccine chief, said Friday. …

Global childhood vax coverage stalled in 2023, 2.7 million kids unprotected, says UN
5 months, 3 weeks ago

Global childhood vax coverage stalled in 2023, 2.7 million kids unprotected, says UN

New Indian Express  

NEW DELHI: Global childhood vaccination coverage stalled in 2023, leaving an estimated 2.7 million children more un- and under-vaccinated compared to pre-pandemic levels in 2019, according to the UN on Monday. Warning of an alarming coverage gap that has led to an outbreak of diseases like malaria, the latest World Health Organisation and UNICEF estimates of national immunisation coverage said …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 3 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times  

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
1 year, 9 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times  

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

Cervical cancer vaccine availability to be boosted next year: Adar Poonawalla
1 year, 11 months ago

Cervical cancer vaccine availability to be boosted next year: Adar Poonawalla

Live Mint  

Serum Institute of India Chief Executive Officer Adar Poonawalla said on Wednesday that the availability of the cervical cancer vaccine will be little in number in 2023. Speaking of the rollout of the cervical cancer vaccines, Adar Poonawalla said the vaccines would be rolled out through government programmes this year. The first made-in-India Human Papillomavirus "CERVAVAC" vaccine, for the prevention …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
2 years ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla
2 years ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times  

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla
2 years ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint  

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

Omicron boosters for the youngest children are here. Will they make a difference?
2 years ago

Omicron boosters for the youngest children are here. Will they make a difference?

LA Times  

Updated COVID-19 booster shots are now available for the youngest children in California, a welcome development for officials hoping to augment vaccine coverage and head off a viral resurgence this winter. “We’re always concerned with lower vaccination rates among children,” said Los Angeles County Public Health Director Barbara Ferrer, “in particular because, as we’ve seen, some children will still get …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

FDA clears updated COVID-19 vaccines for kids under age 5
2 years, 1 month ago

FDA clears updated COVID-19 vaccines for kids under age 5

Associated Press  

U.S. regulators on Thursday cleared doses of the updated COVID-19 vaccines for children younger than age 5. “Vaccination is the best way we know to help prevent the serious outcomes of COVID-19, such as hospitalization and death,” Dr. Peter Marks, FDA’s vaccine chief, told The Associated Press. The FDA decided that: --Children under age 6 who’ve already gotten two original …

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla
2 years, 4 months ago

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla

News 18  

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday. “The original Novovax vaccine Covovax covers omicron and there is good data for it. We will try to launch Omicron-specific vaccine after six months,” he said. The Pune-based Serum Institute is working with US biotechnology major Novavax …

Cervical cancer vaccine to be launched in few months
2 years, 4 months ago

Cervical cancer vaccine to be launched in few months

Firstpost  

Initially, the vaccine will be made available through the government channel and from next year onwards some private partners would be involved too New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs …

Pfizer COVID vaccine 73% effective in children aged between 6 months and 4 years
2 years, 4 months ago

Pfizer COVID vaccine 73% effective in children aged between 6 months and 4 years

Live Mint  

Pfizer said that its COVID vaccine is 73.2% effective in the age group of 6 months to 4 years. The updated data released on Tuesday showed 13 children had COVID-19, at least seven days after receiving a third dose of the Pfizer-BioNTech COVID-19 vaccine, compared with 21 cases in those who received a placebo. The companies also said they were …

Tackling the new variants
2 years, 4 months ago

Tackling the new variants

Hindustan Times  

The first redesigned coronavirus vaccine was approved for use this week when authorities in the United Kingdom cleared a Moderna dose that the company adapted to create immunity against the Omicron variant. The vaccine is a 50-50 formulation of Moderna’s 2020 product, designed on the Sars-CoV-2 variant that first spread around the world, and of a new dose developed using …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 5 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 5 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

India's cumulative Covid-19 vaccination nears 200 crore
2 years, 5 months ago

India's cumulative Covid-19 vaccination nears 200 crore

India Today  

The cumulative Covid-19 vaccine doses administered in the country neared the 200-crore mark on Saturday, the Union health ministry said. Over 14.94 lakh precaution doses of COVID-19 vaccines were given to people in the 18-59 age group till 10 pm, with the majority administered for free under the government's special 75-day drive 'COVID Vaccination Amrit Mahotsav'. The next phase of …

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group
2 years, 5 months ago

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group

India TV News  

Over 13.3 lakh precaution doses of COVID-19 vaccines were administered to beneficiaries in the age group of 18-59 years till 10 pm on Friday, with a majority of those being free under a special 75-day drive launched by the government. The "COVID Vaccination Amrit Mahotsav" to provide free precaution doses of the vaccines to everyone aged 18 years and above …

DC Edit | A good move, as Covid cases up
2 years, 5 months ago

DC Edit | A good move, as Covid cases up

Deccan Chronicle  

The decision of the Union government to push the vaccination programme further against Covid-19 by making the precaution dose free for those who are aged above 18 years has come not one day sooner. That only one per cent of the eligible population aged between 18 and 59 has got the precaution dose calls on the government to redouble its …

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults
2 years, 5 months ago

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults

India TV News  

Highlights US regulators OK new COVID-19 shot option from Novavax vaccine Food and Drug Administration on Wednesday cleared Novavax shots for adults in US Novavax makes more traditional type of shot than three other COVID vaccines available for use in US COVID-19 news : The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday …

Free Covid booster doses will create healthier country: PM Modi
2 years, 5 months ago

Free Covid booster doses will create healthier country: PM Modi

India Today  

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free precautionary doses of Covid-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country. As part of 'Azadi Ka Amrit Mahotsav' celebrations, free precautionary doses of Covid-19 vaccines will be administered to all citizens above the age of 18 at …

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres
2 years, 5 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu  

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 6 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18  

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 6 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint  

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

Just 300,000 children under five years old - less than 1.6% - have got their first Covid jab
2 years, 6 months ago

Just 300,000 children under five years old - less than 1.6% - have got their first Covid jab

Daily Mail  

Barely one in 70 children under five years old have got their first dose of the Covid vaccine despite it being approved last month. But three weeks into the drive a senior White House source told CNN that only 300,000 children have been brought forward for the jab, less than 1.6 percent of the 19million-odd who are eligible. Children aged …

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 6 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US
2 years, 6 months ago

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US

India Today  

The government has allowed Serum Institute of India to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said on Friday. "It is a matter of pride for us and our country that, in …

FDA advisers recommend updating COVID booster shots for fall
2 years, 6 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 6 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds
2 years, 6 months ago

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds

News 18  

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. "The Subject Expert Committee on Covid-19 of the CDSCO deliberated on the EUA application of SII and recommended granting emergency use authorisation for Covovax for children aged 7 to 11 years," …

2 million California kids are now eligible for COVID vaccine. How many will get it?
2 years, 6 months ago

2 million California kids are now eligible for COVID vaccine. How many will get it?

LA Times  

Callum Diaz-Cheng, 3, in the arms of his father, Dr. Andrew Cheng, is vaccinated against COVID-19 Tuesday at Children’s Hospital Los Angeles. “We’ve been waiting for this for a really long time.” Sofia Espinoza Tam is held by her father, Children’s Hospital Los Angeles pediatrician Dr. Juan Espinoza, while nurse Monica Lopez administers the Pfizer COVID-19 vaccine Tuesday. I’m more …

US opens COVID vaccine to little kids; shots begin this week
2 years, 6 months ago

US opens COVID vaccine to little kids; shots begin this week

Associated Press  

NEW YORK — The U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. “We know millions of parents and caregivers are eager to get their young children vaccinated, and with today’s decision, they can,” Walensky said in a statement. The shots offer young children protection from hospitalization, death and possible long-term complications that are still not clearly understood, …

US to roll out COVID vaccines for youngest children next week
2 years, 6 months ago

US to roll out COVID vaccines for youngest children next week

Al Jazeera  

US to begin vaccinating children as young as six months after CDC clears Pfizer-BioNTech and Moderna’s shots for infants, toddlers and preschoolers. The United States Centers for Disease Control and Prevention has approved COVID-19 vaccines for children as young as six months, allowing a nationwide rollout to start next week. The US Food and Drug Administration on Friday authorized Moderna …

CDC recommends Covid-19 vaccines for children as young as 6 months, clearing the way for vaccinations to begin soon
2 years, 6 months ago

CDC recommends Covid-19 vaccines for children as young as 6 months, clearing the way for vaccinations to begin soon

CNN  

CNN — US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky signed off on Covid-19 vaccinations for children under 5 on Saturday, clearing the way for vaccinations to be administered soon. “Today is a monumental step forward in our nation’s fight against the virus, with virtually every American now eligible for the protections that COVID-19 vaccines provide,” Biden …

What parents should know about Covid-19 vaccines for children under 5
2 years, 6 months ago

What parents should know about Covid-19 vaccines for children under 5

CNN  

CNN — The US Food and Drug Administration gave emergency use authorization on Friday for both the Pfizer/BioNTech and Moderna vaccines for young children. Just 18% of parents of children under 5 said they would vaccinate their child against Covid-19 as soon as a vaccine became available, according to an April Kaiser Family Foundation Vaccine Monitor survey. Nearly 40% of …

FDA authorizes 1st COVID-19 shots for infants, preschoolers
2 years, 6 months ago

FDA authorizes 1st COVID-19 shots for infants, preschoolers

Associated Press  

U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The FDA also authorized Moderna’s vaccines for school-aged children and teens; CDC’s review is next week. While young children generally don’t get as sick from COVID-19 as older kids and adults, their hospitalizations surged during the omicron wave …

Discover Related